July 2016 Br J Cardiol 2016;23:106–9 doi:10.5837/bjc.2016.025 Online First
Blandina Gomes, Kamen Valchanov, William Davies, Adam Brown, Peter Schofield
Abstract
Introduction
Papworth Hospital NHS Trust, Cambridge
Spinal cord stimulation (SCS) therapy has been used for more than four decades in a variety of chronic pain conditions. The introduction of neurostimulation was a logical consequence of the ‘gate-control’ theory published in 1965.1 According to this model, the activation of large afferent nerve fibres inhibits pain input mediated by small fibres into the dorsal horn of the spinal cord. The goal of SCS is to attenuate discomfort by provoking paraesthesia in the same area.
The European Society of Cardiology defines refractory angina as a chronic condition characterised by the presence of a
|
Full text